| S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis (NCT03499808) | SWOG Cancer Research Network | 2018-06-06 |
| Doxycycline to Upgrade Organ Response in Light Chain (AL) Amyloidosis Trial (NCT02207556) | Medical College of Wisconsin | 2014-10-01 |
| Autologous Stem Cell Transplant Followed By Maintenance Therapy in Treating Elderly Patients With Multiple Myeloma (NCT01849783) | Margarida Magalhaes-Silverman | 2013-04-04 |
| First-line Pomalidomide, Bortezomib, and Dexamethasone For AL Amyloidosis or LCDD (NCT01728259) | Barbara Ann Karmanos Cancer Institute | 2013-03-01 |
| Infection Prophylaxis and Management in Treating Cytomegalovirus (CMV) Infection in Patients With Hematologic Malignancies Previously Treated With Donor Stem Cell Transplant (NCT01199562) | City of Hope Medical Center | 2010-12-01 |
| Melphalan and Dexamethasone With or Without Bortezomib in Treating Patients With Previously Untreated Systemic Light-Chain Amyloidosis (NCT01078454) | National Cancer Institute (NCI) | 2010-11-01 |
| Lendexal in Patients With Primary Systemic Amyloidosis (AL) Newly Diagnosed (NCT01194791) | PETHEMA Foundation | 2010-10-01 |
| Massage Therapy Given by Caregiver in Treating Quality of Life of Young Patients Undergoing Treatment for Cancer (NCT01053494) | Wake Forest University Health Sciences | 2010-04-01 |
| Bortezomib, Cyclophosphamide, and Dexamethasone in Treating Patients With Primary Systemic Light Chain Amyloidosis (NCT01072773) | Mayo Clinic | 2010-03-01 |
| Sunitinib Malate in Treating HIV-Positive Patients With Cancer Receiving Antiretroviral Therapy (NCT00890747) | National Cancer Institute (NCI) | 2009-08-01 |
| Bortezomib, Melphalan, and Dexamethasone in Treating Patients With Primary Amyloidosis or Light Chain Deposition Disease (NCT00520767) | Barbara Ann Karmanos Cancer Institute | 2007-09-01 |
| High-Dose Chemotherapy With or Without Total-Body Irradiation Followed by Autologous Stem Cell Transplant in Treating Patients With Hematologic Cancer or Solid Tumors (NCT00536601) | Roswell Park Cancer Institute | 2006-06-29 |
| Iododoxorubicin in Treating Patients With Primary Systemic Amyloidosis (NCT00030381) | National Cancer Institute (NCI) | 2001-12-01 |
| Imatinib Mesylate in Treating Patients With Advanced Cancer and Liver Dysfunction (NCT00025415) | National Cancer Institute (NCI) | 2001-08-01 |
| Phase II Trial of Enbrel in Patients With Primary Systemic Amyloidosis (NCT00224393) | The Cleveland Clinic | 2001-02-01 |
| Fludarabine Phosphate and Total-Body Radiation Followed by Donor Peripheral Blood Stem Cell Transplant and Immunosuppression in Treating Patients With Hematologic Malignancies (NCT00014235) | Fred Hutchinson Cancer Center | 2000-12-01 |
| Fludarabine and Total-Body Irradiation Followed By Donor Stem Cell Transplant and Cyclosporine and Mycophenolate Mofetil in Treating HIV-Positive Patients With or Without Cancer (NCT00112593) | Fred Hutchinson Cancer Center | 1999-11-01 |